ESC 365 - Paradigm shifts in HFrEF management: SGLT2-Inhibitors

Open Access

Paradigm shifts in HFrEF management: SGLT2-Inhibitors

Event: ESC Asia with APSC & AFC 2020

Topic: Chronic Heart Failure

Session type: Industry Technology and Innovation session

Sponsored by AstraZeneca

Date: 5 December 2020

Time: 18:00 - 18:30

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

2 presentations in this session

Paradigm shifts in HFrEF management: SGLT2-Inhibitors.

Q&A - Paradigm shifts in HFrEF management: SGLT2-Inhibitors.

Speaker: Professor C. Chiang (Taipei, TW)

Speaker: Associate Professor J. Tan (Singapore, SG)

2 speakers from this session

Professor Chern-En Chiang

Taipei Veterans General Hospital, Taipei (Taiwan)

1 presentation

0 follower

Associate Professor Jack Wei Chieh Tan

National Heart Centre Singapore, Singapore (Singapore)

14 presentations

2 followers

This platform is supported by